Welcome to our dedicated page for Balchem SEC filings (Ticker: BCPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Balchem Corporation filings document financial results, governance matters, shareholder votes, and material events for a specialty ingredient manufacturer with Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products segments. Form 8-K reports attach quarterly and annual earnings releases with segment performance, cash flow measures, balance sheet items, debt, and capital-allocation disclosures.
Proxy and shareholder-meeting filings describe board elections, auditor ratification, advisory executive-compensation votes, meeting procedures, corporate governance practices, and executive compensation. Other material-event reports record officer transitions and related governance disclosures, while exhibit and Inline XBRL records support the company’s public reporting framework.
Balchem Corporation furnished an update on its business by reporting earnings for the quarter ended September 30, 2025. The company issued a press release with the results, which is attached as Exhibit 99.1.
The disclosure was provided under Item 2.02 and is designated as “furnished,” meaning it is not deemed filed under Section 18 of the Exchange Act. Balchem’s common stock trades on Nasdaq under the symbol BCPC.
Balchem Corp. (BCPC) EVP, Chief Legal Officer & Secretary Hatsuki Miyata filed a Form 4 reporting an internal share withholding associated with restricted-stock vesting.
- Transaction: On 07/25/2025, 483 common shares were automatically withheld (code “F”) to satisfy tax obligations at a reported price of $148.82, representing roughly $72 k of tax value.
- Post-transaction ownership: 6,189 shares held directly; 462 shares held indirectly through the company 401(k) plan.
- Interpretation: Code F is a non-discretionary event; no open-market buying or selling occurred, so investment signal is neutral.
No derivative securities were involved and there is no impact on Balchem’s capital structure.
Balchem Corporation held its Annual Meeting of Shareholders on June 18, 2025, where three significant matters were put to vote:
- Board Elections: Three Class 1 directors were elected to serve until 2028: - Theodore L. Harris (24.9M votes for) - Monica Vicente (26.4M votes for) - Matthew Wineinger (26.1M votes for)
- Auditor Appointment: Shareholders strongly approved RSM US LLP as the independent registered public accounting firm for FY2025, with 28.8 million votes in favor (98.2% approval)
- Executive Compensation: The say-on-pay vote passed with 25.4 million votes in favor (93.6% of votes cast), showing strong shareholder support for the company's executive compensation practices
All proposals received substantial shareholder approval, indicating strong governance alignment and shareholder satisfaction with the company's direction.